Pulling SEC filings + quote and writing the call…

Blend Labs, Inc.
Last earnings +1.3% on 2026-05-07
Real turnaround — losses nearly gone, no debt, cash-flow positive — but sub-7% growth and P/S 3.7 leave no bargain.
Revenue (FY2025) $124M (YoY +6.8%) · FY2025
Blend is a credible turnaround that isn't yet a quality business. The bottom line has healed dramatically: net loss narrowed to -$6.80M in FY2025 from -$43.3M (FY2024), -$179M (FY2023) and a -$720M blowout in FY2022, and operating cash flow swung to +$11.5M (+188%). Gross margin of 73.8% is genuinely SaaS-grade, and the balance sheet carries zero long-term debt, $43.6M cash and a ~2.4x current ratio ($139M current assets vs. $57.6M current liabilities) — enough runway to finish the job. That combination is why this is a hold, not an avoid.
But the quality bar isn't cleared. Revenue is $124M, roughly half the $234–235M of 2021–2022 (partly the Title segment reclassified to discontinued ops, per Note 16), and forward growth is only +6.8% — thin for a name at P/S 3.7. The company still loses money at the operating line (-17.6% margin), equity is negative (-$17.2M) against a -$1.39B accumulated deficit, and R&D was cut 28.7%, which flatters near-term cash but questions the growth engine. The MD&A confirms a success-based, self-reported revenue model that is hard to forecast and, per the Risk Factors, 'substantially dependent' on mortgage volumes and 'adversely affected' by higher rates — so the improving trend is levered to a cycle management doesn't control.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $234M | $235M | $110M | $116M | $124M |
| Gross profit | $116M | $89.7M | $76.5M | $83.2M | $91.2M |
| Operating income | -$197M | -$746M | -$144M | -$48.8M | -$21.7M |
| Net income | -$170M | -$720M | -$179M | -$43.3M | -$6.80M |
| Diluted EPS | -$1.30 | -$3.28 | -$0.76 | -$0.24 | -$0.10 |
| Net margin | -72.5% | -306.2% | -163.1% | -37.4% | -5.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Item 5.07: annual meeting vote results certified; directors elected as proposed
Q1 2026: reports on continuing ops only after Title segment divestiture
Q1 2026: reports on continuing ops only after Title segment divestiture
2026 proxy: board slate and executive comp put to annual meeting
FY2025 loss cut to $6.8M, OCF +$11.5M; but two ICFR material weaknesses flagged
FY2025 results: revenue +7%, net loss narrowed ~84% to $6.8M, OCF turned positive
Reg FD (7.01) investor/conference disclosure; no financial change
Reg FD disclosure with exhibit; no material financial change
Q3 2025: Title business reclassified as discontinued operations
Sources: SEC EDGAR (CIK 0001855747, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 7/3/2026, 5:13:10 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 3 open-market buys · 0 sales
| 2026-06-15 | Haveli Investments, L.P. Director | Buy | 650K @ $1.72 | $1.12M |
| 2026-06-12 | Haveli Investments, L.P. Director | Buy | 257K @ $1.70 | $436K |
| 2026-06-11 | Haveli Investments, L.P. Director | Buy | 250K @ $1.74 | $435K |
| 2026-06-11 | Woersching Eric H. Director | Exercise | 50.0K | |
| 2026-06-11 | Sullivan Bryan Edmund Director | Exercise | 50.0K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1196 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.